GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS
Journal Article
Devanur, L., Pelligand, L., Hassard, S., & Elliott, J. GFR MEASUREMENTS IN FELINE SUBJECTS USING HIGH PERFORMANCE CAPILLARY ELECTROPHORESIS. Journal of Veterinary Pharmacology and Therapeutics, 35, 174-174
All Outputs (110)
CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA
Journal Article
Kenward, H., Pelligand, L., Tattersall, F. D., Savary-Bataille, K., & Elliott, J. CISPLATIN-INDUCED EMESIS IN DOGS: EVALUATION OF ARGININE VASOPRESSIN AND CORTISOL AS BIOMARKERS OF NAUSEA. Journal of Veterinary Pharmacology and Therapeutics, 35, 32-33
THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA
Journal Article
Pelligand, L. THE NEXT GENERATION THERAPEUTICS FOR VETERINARY ANALGESIA. Journal of Veterinary Pharmacology and Therapeutics, 35, 55-55
Development and validation of a tissue cage model of acute inflammation in the cat
Journal Article
Pelligand, L., House, A. K., Summers, B. A., Hatzis, A., Tivers, M. S., Elliott, J., & Lees, P. Development and validation of a tissue cage model of acute inflammation in the cat. Journal of Veterinary Pharmacology and Therapeutics, 35(3), 239-248. https://doi.org/10.1111/j.1365-2885.2011.01308.x
PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT
Journal Article
Pelligand, L., King, J. N., Hormazabal, V., Toutain, P. L., Elliott, J., & Lees, P. PHARMACOKINETICS AND PHARMACOKINETIC/PHARMACODYNAMIC MODELLING OF ROBENACOXIB AND KETOPROFEN IN A CARRAGEENAN-INDUCED INFLAMMATION MODEL IN THE CAT. Journal of Veterinary Pharmacology and Therapeutics, 35, 56-57
Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation
Journal Article
Pelligand, L., King, J. N., Toutain, P. L., Elliott, J., & Lees, P. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation. Journal of Veterinary Pharmacology and Therapeutics, 35(1), 19-32. https://doi.org/10.1111/j.1365-2885.2011.01288.x
Development and validation of a timed urinary collection system for use in the cat.
Journal Article
Pelligand, L., Lees, P., & Elliott, J. Development and validation of a timed urinary collection system for use in the cat. Laboratory Animals, 45(3), 196-203. https://doi.org/10.1258/la.2011.010153
PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS
Journal Article
Lees, P., Giraudel, J., Toutain, P. L., Pelligand, L., & King, J. N. PK-PD INTEGRATION AND PK-PD MODELLING OF PREFERENTIAL AND SELECTIVE COX-2 INHIBITORS: TOWARDS SAFER DRUGS AND IMPROVED DOSAGE REGIMENS. Journal of Veterinary Pharmacology and Therapeutics, 32, 33-36
IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION
Journal Article
Pelligand, L., King, J. N., Toutain, P. L., & Lees, P. IN VIVO COX-2 SELECTIVITY OF ROBENACOXIB IN A FELINE TISSUE CAGE MODEL OF INFLAMMATION. Journal of Veterinary Pharmacology and Therapeutics, 32, 103-104
An investigation of the bacterial contamination of small animal breathing systems during routine use
Journal Article
Pelligand, L., Hammond, R. A., & Rycroft, A. N. An investigation of the bacterial contamination of small animal breathing systems during routine use. Veterinary Anaesthesia and Analgesia, 34(3), 190-199. https://doi.org/10.1111/j.1467-2995.2006.00320.x